Acute Ocular Pain Aop Epidemiology Forecast

DelveInsight’s ‘Acute Ocular Pain (AOP)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the AOP, historical and forecasted epidemiology as well as the AOP trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018–2030

Acute Ocular Pain (AOP) Disease Understanding

Eye pain is a myriad of symptoms ranging from a sharp pain in the eye to mild discomfort or itching in the eyes. As the spectrum of symptom presentation varies with eye pain, the cause of these pains may vary from straightforward refractive errors to potentially sight-threatening disorders like glaucoma and uveitis. A feeling of discomfort or pain in the eye can be caused by a problem in the eye itself. It can also be caused by a problem involving any structures around the eye or referred pain from tissues with similar innervation as ocular tissues (V1). Patients with eye pain or periorbital pain frequently present to primary care physicians, neurologists, or ophthalmologists.


Most ophthalmologic conditions producing ocular pains are associated with obvious ocular symptoms and signs like red-eye, photophobia, vision loss, or diplopia. Sometimes it poses a challenge to physicians when the pain is associated with a quiet eye or “white eye”.


Depending on where the patients experience the discomfort, eye pain can fall into one of two categories: Ocular pain occurring on the eye’s surface and orbital pain within the eye.


Eye pain that occurs on the surface may be scratching, burning, or itching sensation. Surface pain is usually caused by irritation from a foreign object, infection, or trauma. Often, this type of eye pain is easily treated with eye drops or rest.

Continued in the report…..

Acute Ocular Pain (AOP) Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Number of Cases of Several Eye Disorders and Number of Cases of Acute Ocular Pain in Major Eye Disorders scenario in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Acute Ocular Pain (AOP) Detailed Epidemiology Segmentation

  • In the year 2020, the total cases of Acute Ocular Pain (AOP) were estimated to be 15,029,051 cases in the 7MM, which might increase in 2030 at a CAGR of 0.65%.
  • According to DelveInsight estimates, in 2020, it was estimated that there were 461,948, 14,243, 98,281, 710,949, 1,268,905, and 4,050,494 cases of Cataract Surgeries, Uveitis, Glaucoma Surgeries, Corneal Aberration Surgeries, Dry eye disease, and Conjunctivitis respectively that experienced acute ocular pain, in the United States.
  • Among EU5 countries, Spain has the lowest number of cases of Acute Ocular Pain (AOP), which were estimated to be 1,106,840 cases in 2020.
  • In Japan, 874,788 cases of AOP were estimated, which might rise in 2030.


“There are several disorders where the patients complain of the AOP. The majority of the disorders includes Cataract Surgeries, Uveitis, Glaucoma Surgeries, Corneal Aberrations Surgery, Dry Eye Disease, and conjunctivitis, in which AOP is usually experienced. In the case of Dry eye disease, the patient with severe disease mostly experiences acute ocular pain, and the prevalence is around 20–25%. Patients suffering from corneal aberration generally go for LASIK surgery, where almost all patients experience AOP.”

Scope of the Report

  • The report covers the descriptive overview of AOP, explaining its causes, symptoms, pathophysiology, and genetic basis.
  • The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of AOP.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for 7MM by Number of Cases of Several Eye Disorders and Number of Cases of Acute Ocular Pain in Major Eye Disorders.

Report Highlights

  • 10-Year Forecast of AOP
  • 7MM Coverage
  • Number of Cases of Several Eye Disorders
  • Number of Cases of Acute Ocular Pain in Major Eye Disorders

Key Questions Answered

  • What are the disease risk, and burden of AOP?
  • What is the historical AOP patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
  • What would be the forecasted patient pool of AOP at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to AOP?
  • Out of the above-mentioned countries, which country would have the highest population of AOP during the forecast period (2021–2030)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2021–2030)?

Reasons to buy

The AOP report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the 7MM AOP epidemiology forecast.
  • The AOP epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The AOP epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Report Introduction

3. Acute Ocular Pain (AOP) Epidemiology Overview at a Glance

4. Executive Summary of Acute Ocular Pain (AOP)

5. Acute Ocular Pain (AOP): Future Perspective

6. Disease Background and Overview

6.1. Introduction

6.2. Eye: Components and Anatomy

6.3. Causes

6.3.1. Ocular trauma

6.3.2. Conjunctival or corneal foreign body

6.3.3. Recurrent corneal erosions (RCE)

6.3.4. Dry eyes

6.3.5. Microbial keratitis

6.3.6. Glaucoma

6.3.7. Episcleritis

6.3.8. Scleritis

6.3.9. Uveitis

6.3.10. Optic neuropathies

6.3.11. Eye pain in cranial nerve palsies

6.3.12. Eye pain in ocular asthenopia

6.3.13. Eye pain in migraine

6.3.14. Eyelid, orbit, and ocular adnexa

6.3.15. Ocular surface, conjunctiva, and cornea

6.3.16. Retinal diseases

6.4. Diagnosis

6.4.1. History

6.4.2. Physical examination

6.4.3. Testing

6.5. Differential Diagnosis and Management

6.6. Treatment and Management

6.6.1. Local treatment

6.6.1.1. Topical Ophthalmic NSAIDs

6.6.1.2. Ophthalmic Corticosteroids

6.6.1.3. Cholinergic Antagonists

6.6.1.4. Topical Anesthetics

6.6.2. Allergy eye drops

6.6.3. Surgery

7. Epidemiology and Patient Population

7.1. Key Findings

7.2. Epidemiology Methodology

7.3. Total Cases of Several Eye Disorders in the 7MM

7.4. Total Cases of Acute Ocular Pain (AOP) in the 7MM

7.5. Epidemiology of Acute Ocular Pain (AOP)

7.6. The United States

7.6.1. Number of Cases of Several Eye disorders in the United States

7.6.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in the United States

7.7. EU5

7.7.1. Germany

7.7.1.1. Number of Cases of Several Eye Disorders in Germany

7.7.1.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in Germany

7.7.2. France

7.7.2.1. Number of Cases of Several Eye Disorders in France

7.7.2.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in France

7.7.3. Italy

7.7.3.1. Number of Cases of Several Eye Disorders in Italy

7.7.3.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in Italy

7.7.4. Spain

7.7.4.1. Number of Cases of Several Eye Disorders in Spain

7.7.4.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in Spain

7.7.5. United Kingdom

7.7.5.1. Number of Cases of Eye Disorders in the UK

7.7.5.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in the UK

7.8. Japan

7.8.1. Number of Cases of Several Eye Disorders in Japan

7.8.2. Number of Cases of Acute Ocular Pain in Major Eye Disorders in Japan

8. Appendix

8.1. Bibliography

8.2. Report Methodology

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

List of Table

Table 1: Summary of Acute Ocular Pain (AOP), Epidemiology, and Key Events (2018–2030)

Table 2: History Findings Suggestive of Different Causes of Eye Pain

Table 3: Physical Examination Findings Suggestive of Different Causes of Eye Pain

Table 4: Differential Diagnosis of Eye Pain

Table 5: Total Cases of Several Eye Disorders in the 7MM, in Thousand (2018–2030)

Table 6: Total Cases of Acute Ocular Pain (AOP) in the 7MM, in Thousand (2018–2030)

Table 7: Incidence of Acute Ocular pain in individuals with predisposing conditions

Table 8: Number of Cases of Several Eye Disorders in the United States, in Thousand (2018–2030)

Table 9: Number of Cases of Acute Ocular Pain in Major Eye Disorders in the US, in Thousand (2018–2030)

Table 10: Number of Cases of Several Eye Disorders in Germany, in Thousand (2018–2030)

Table 11: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Germany, in Thousand (2018–2030)

Table 12: Number of Cases of Several Eye Disorders in France, in Thousand (2018–2030)

Table 13: Number of Cases of Acute Ocular Pain in Major Eye Disorders in France, in Thousand (2018–2030)

Table 14: Number of Cases of Several Eye Disorders in Italy, in Thousand (2018–2030)

Table 15: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Italy, in Thousand (2018–2030)

Table 16: Number of Cases of Several Eye Disorders in Spain, in Thousand (2018–2030)

Table 17: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Spain, in Thousand (2018–2030)

Table 18: Number of Cases of Several Eye Disorders in the UK, in Thousand (2018–2030)

Table 19: Number of Cases of Acute Ocular Pain in Major Eye Disorders in the UK, in Thousand (2018–2030)

Table 20: Number of Cases of Several Eye Disorders in Japan, in Thousand (2018–2030)

Table 21: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Japan, in Thousand (2018–2030)

List of Figures

Figure 1: Anatomy of the eye.

Figure 2: Causes of eye pain

Figure 3: Diagnosing the Cause of Eye Pain

Figure 4: Total Cases of Several Eye Disorders in the 7MM (2018–2030)

Figure 5: Total Cases of Acute Ocular Pain (AOP) in the 7MM (2018–2030)

Figure 6: Number of Cases of Several Eye Disorders in the United States (2018–2030)

Figure 7: Number of Cases of Acute Ocular Pain in Major Eye Disorders in the US (2018–2030)

Figure 8: Number of Cases of Several Eye Disorders in Germany (2018–2030)

Figure 9: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Germany (2018–2030)

Figure 10: Number of Cases of Several Eye Disorders in France (2018–2030)

Figure 11: Number of Cases of Acute Ocular Pain in Major Eye Disorders in France (2018–2030)

Figure 12: Number of Cases of Several Eye Disorders in Italy (2018–2030)

Figure 13: Number of Cases of Acute Ocular Pain in Major Several Eye Disorders in Italy (2018–2030)

Figure 14: Number of Cases of Several Eye Disorders in Spain (2018–2030)

Figure 15: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Spain (2018–2030)

Figure 16: Number of Cases of Several Eye Disorders in the UK (2018–2030)

Figure 17: Number of Cases of Acute Ocular Pain in Major Eye Disorders in the UK (2018–2030)

Figure 18: Number of Cases of Several Eye Disorders in Japan (2018–2030)

Figure 19: Number of Cases of Acute Ocular Pain in Major Eye Disorders in Japan (2018–2030)

  • Tags:
  • Acute Ocular Pain (AOP) Epidemiolog...
  • Acute Ocular Pain (AOP)
  • Acute Ocular Pain (AOP) Pipeline
  • Acute Ocular Pain (AOP) Companies
  • Acute Ocular Pain (AOP) prevalent...
  • Acute Ocular Pain (AOP) incident p...
  • Acute Ocular Pain (AOP) patients d...
  • Acute Ocular Pain (AOP) treatment...

Forward to Friend

Need A Quote